Biotech Stories

Canadian Stories

Biotech stories

Feds back GTA AI projects with CAD $16.5M investment

The grants are set to speed the rollout of AI tools across healthcare, manufacturing and finance, helping GTA firms reach market sooner.

By Jake MacAndrew • 3 min read • Last month

Health Technologies

Canadian healthtech saw $900M VC funding decline in 2025

Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.

By Jake MacAndrew • 4 min read • Last month

Artificial Intelligence

MaRS expert panel divided on Canada's health future

Canada’s health tech sector is struggling to turn strong research into commercial scale, as panellists split over whether policy or private capital should lead.

By Jake MacAndrew • 4 min read • Tue, 28th Apr 2026

Global Stories

Biotech stories

Data Analytics

OpenAI updates GPT-Rosalind for life sciences research

Eligible research organisations can now access OpenAI's updated GPT-Rosalind model, as the company widens its life sciences rollout worldwide.

By Mark Tarre • 4 min read • Last week

Document Management

Veeva launches Falcon AI platform for drug development

The platform targets manual drug-development bottlenecks, from trial documents to safety case intake, as biopharma seeks faster compliant workflows.

By Joseph Gabriel Lagonsin • 3 min read • Last week

Data governance

Persistent wins Databricks healthcare & life sciences

The new specialisation should help healthcare and life sciences firms use governed AI and data tools to speed trials, discovery and patient insights.

By Mark Tarre • 4 min read • Last month

Data Protection

AI use in life sciences focused on augmentation - for now

AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.

By David Shilovsky • 5 min read • Last month

Document Management

i-GENTIC expands GENIE to cover FDA compliance lifecycle

Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.

By Joseph Gabriel Lagonsin • 5 min read • Last month

Data Analytics

OpenAI launches GPT-Rosalind for life sciences research

Research teams could see faster target discovery as OpenAI opens GPT-Rosalind to qualified US customers for biology and drug discovery work.

By Mark Tarre • 4 min read • Sat, 18th Apr 2026

Quantum Computing

Kvantify hires Dr David Siebert to lead global business development

The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.

By Sofiah Nichole Salivio • 4 min read • Wed, 15th Apr 2026

Semiconductors

US AI megadeals drive global VC to USD $331 billion

A handful of US artificial intelligence megadeals pushed global venture capital investment to USD $330.9 billion in the first quarter, KPMG said.

By Karen Joy Bacudo • 4 min read • Wed, 15th Apr 2026

Digital Transformation

ACTO launches role-based AI SuperAgents for Life Sciences

Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.

By Joseph Gabriel Lagonsin • 4 min read • Wed, 15th Apr 2026

Stories from Other Regions

Biotech stories

Semiconductors

Cambridge Tech Week unveils first 2026 speaker line-up

Five days of talks in Cambridge will focus on how deep tech can scale internationally, with energy, AI and investment leaders set to attend.

By Regine Laguilles • 4 min read • Yesterday

Fintech

UK tech sector valued at GBP £1.6 trillion, report finds

Artificial intelligence has become the main driver of UK tech value, with venture funding and start-up creation increasingly concentrated in the sector.

By Sofiah Nichole Salivio • 3 min read • 2 days ago